Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Young-Min Lim

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Journal of the Neurological Sciences|September 7, 2024
Potential prognostic value of rheumatoid factor in anti-aquaporin 4-immunoglobin G-positive neuromyelitis optica spectrum disordersHye Lim Lee, Jin Myoung Seok, Soon-Young Hwang, et al.
Journal of Korean Medical Science|May 14, 2024
Impact of COVID-19 Infection and Its Association With Previous Vaccination in Patients With Myasthenia Gravis in Korea: A Multicenter Retrospective StudyHee Jo Han, Seung Woo Kim, Hyunjin Kim, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2025
Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated diseaseYou-Ri Kang, Hyunjin Ju, Ki Hoon Kim, et al.
JAMA Neurology|September 3, 2024
Time to Treat First Acute Attack of Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseYoung Nam Kwon, Boram Kim, Jun-Soon Kim, et al.
Journal of Neurology|November 17, 2022
Clinical pitfalls and serological diagnostics of MuSK myasthenia gravisYoung Nam Kwon, Mark Woodhall, Jung-Joon Sung, et al.
Journal of Clinical Neurology (Seoul, Korea)|March 11, 2025
Evaluating Rituximab Failure Rates in Neuromyelitis Optica Spectrum Disorder: A Nationwide Real-World Study From South KoreaSu-Hyun Kim, Ju-Hong Min, Sung-Min Kim, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2020
Comparison of MOG and AQP4 antibody seroprevalence in Korean adults with inflammatory demyelinating CNS diseasesJae-Won Hyun, Hye Lim Lee, Woo Kyo Jeong, et al.
JAMA Network Open|February 13, 2026
Disability and Relapse Risk in Late-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseHyunjin Ju, Ki Hoon Kim, Sook Young Woo, et al.
Neurology|March 12, 2026
Prevalence and Relative Proportions of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the Republic of KoreaSu-Hyun Kim, Eun-Jae Lee, Young-Min Lim, et al.
Neurology|May 15, 2026
Prevalence and Relative Proportions of MS, NMOSD, and MOGAD in the Republic of KoreaSu-Hyun Kim, Eun-Jae Lee, Young-Min Lim, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Journal of the Neurological Sciences|September 7, 2024
Potential prognostic value of rheumatoid factor in anti-aquaporin 4-immunoglobin G-positive neuromyelitis optica spectrum disordersHye Lim Lee, Jin Myoung Seok, Soon-Young Hwang, et al.
Journal of Korean Medical Science|May 14, 2024
Impact of COVID-19 Infection and Its Association With Previous Vaccination in Patients With Myasthenia Gravis in Korea: A Multicenter Retrospective StudyHee Jo Han, Seung Woo Kim, Hyunjin Kim, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2025
Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated diseaseYou-Ri Kang, Hyunjin Ju, Ki Hoon Kim, et al.
JAMA Neurology|September 3, 2024
Time to Treat First Acute Attack of Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseYoung Nam Kwon, Boram Kim, Jun-Soon Kim, et al.
Journal of Neurology|November 17, 2022
Clinical pitfalls and serological diagnostics of MuSK myasthenia gravisYoung Nam Kwon, Mark Woodhall, Jung-Joon Sung, et al.
Journal of Clinical Neurology (Seoul, Korea)|March 11, 2025
Evaluating Rituximab Failure Rates in Neuromyelitis Optica Spectrum Disorder: A Nationwide Real-World Study From South KoreaSu-Hyun Kim, Ju-Hong Min, Sung-Min Kim, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2020
Comparison of MOG and AQP4 antibody seroprevalence in Korean adults with inflammatory demyelinating CNS diseasesJae-Won Hyun, Hye Lim Lee, Woo Kyo Jeong, et al.
JAMA Network Open|February 13, 2026
Disability and Relapse Risk in Late-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseHyunjin Ju, Ki Hoon Kim, Sook Young Woo, et al.
Neurology|March 12, 2026
Prevalence and Relative Proportions of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the Republic of KoreaSu-Hyun Kim, Eun-Jae Lee, Young-Min Lim, et al.
Neurology|May 15, 2026
Prevalence and Relative Proportions of MS, NMOSD, and MOGAD in the Republic of KoreaSu-Hyun Kim, Eun-Jae Lee, Young-Min Lim, et al.
Pageof 9